Evidence map›Paper›PMID 31311719›Full record

ArticleMolecular metabolism2019

ATGL-1 mediates the effect of dietary restriction and the insulin/IGF-1 signaling pathway on longevity in C. elegans.

Nava Zaarur, Kathleen Desevin, James Mackenzie, Avery Lord, Alla Grishok, Konstantin V Kandror

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 39 citations in OpenAlex.

  1. Supplementation via DAF-16 andbioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Review
  4. Lipid metabolism in homeostasis and disease.Signal transduction and targeted therapy · 2026
    Review
  5. Article
  6. Lack of Pnpla2 Accelerates Progression of AMD-Like Features in Mice.Investigative ophthalmology & visual science · 2025
    Article
  7. Aging · 2025
    Article
  8. Baicalein fromFrontiers in pharmacology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Nava ZaarurDepartment of Biochemistry, Boston University School of Medicine, Boston, MA, 02118, USA.
Kathleen DesevinDepartment of Biochemistry, Boston University School of Medicine, Boston, MA, 02118, USA.
James MackenzieDepartment of Biochemistry, Boston University School of Medicine, Boston, MA, 02118, USA.
Avery LordDepartment of Biochemistry, Boston University School of Medicine, Boston, MA, 02118, USA.
Alla GrishokDepartment of Biochemistry, Boston University School of Medicine, Boston, MA, 02118, USA. Electronic address: agrishok@bu.edu.
Konstantin V KandrorDepartment of Biochemistry, Boston University School of Medicine, Boston, MA, 02118, USA. Electronic address: kkandror@bu.edu.
Boston University · US

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
Transgenic CoreP30DK046200 · NIDDK · TUFTS MEDICAL CENTER · PI CORKEY, BARBARA E. · 1992 to 2021
$25.0M
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
INSULIN REGULATION OF CELL NUTRITIONR01DK052057 · NIDDK · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KANDROR, KONSTANTIN V · 1997 to 2023
$7.1M
Regulation of lipolysis by mTORC1R01DK107498 · NIDDK · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KANDROR, KONSTANTIN V · 2016 to 2019
$1.5M
Insulin regulation of cell nutritionR56DK052057 · NIDDK · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KANDROR, KONSTANTIN V · 2008 to 2014
$418k
NCATS NIH HHS UL1 TR001430NIDDK NIH HHS P30 DK046200NIDDK NIH HHS R01 DK052057NIDDK NIH HHS R01 DK107498NIDDK NIH HHS R56 DK052057NIH HHS P40 OD010440
6 · The paper itself

Abstract

objectiveAnimal lifespan is controlled through genetic pathways that are conserved from nematodes to humans. Lifespan-promoting conditions in nematodes include fasting and a reduction of insulin/IGF signaling. Here we aimed to investigate the input of the Caenorhabditis elegans homologue of the mammalian rate-limiting lipolytic enzyme Adipose Triglyceride Lipase, ATGL-1, in longevity control.

methodsWe used a combination of genetic and biochemical approaches to determine the role of ATGL-1 in accumulation of triglycerides and regulation of longevity.

resultsWe found that expression of ATGL is increased in the insulin receptor homologue mutant daf-2 in a FoxO/DAF-16-dependent manner. ATGL-1 is also up-regulated by fasting and in the eat-2 loss-of-function mutant strain. Overexpression of ATGL-1 increases basal and maximal oxygen consumption rate and extends lifespan in C. elegans. Reduction of ATGL-1 function suppresses longevity of the long-lived mutants eat-2 and daf-2.

conclusionOur results demonstrate that ATGL is required for extended lifespan downstream of both dietary restriction and reduced insulin/IGF signaling.

Indexed as

Signal TransductionAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsFastingInsulinInsulin-Like Growth Factor ILipaseLongevityATGL-1 protein, C elegansCaenorhabditis elegans ProteinsInsulinInsulin-Like Growth Factor ILipaseATGL-1C. elegansDAF-16DAF-2Dietary restrictionLongevity

Identifiers

PMID31311719
PMCPMC6717769
OpenAlexW2954099651

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.